Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $12.2500 (3.46%) ($11.8300 - $12.5400) on Tue. Jun. 23, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.62% (three month average) | RSI | 60 | Latest Price | $12.2500(3.46%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 3.1% a day on average for past five trading days. | Weekly Trend | ATRA advances 6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(44%) IWO(44%) ARKK(43%) | Factors Impacting ATRA price | ATRA will decline at least -3.81% in a week (0% probabilities). VIXM(-32%) VXX(-27%) UUP(-9%) UNG(-9%) XLC(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.81% (StdDev 7.62%) | Hourly BBV | 0 () | Intraday Trend | 2.1% | | | |
|
5 Day Moving Average | $11.21(9.28%) | 10 Day Moving Average | $10.58(15.78%) | 20 Day Moving Average | $10.57(15.89%) | To recent high | -18% | To recent low | 62.7% | Market Cap | $910m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |